Cited by 26Diabetes and associated disordersDiabetes Management and ResearchAutoimmune Neurological Disorders and Treatments

Glutamic acid decarboxylase autoantibody detection by electrochemiluminescence assay identifies latent autoimmune diabetes in adults with poor islet function

Open access
Zhu, Yuxiao, Qian, Li, Liu, Qing, Zou, Jing, Zhou, Ying, Yang, Tao, Huang, Gan, Zhou, Zhiguang +1 more·2020·Diabetes & Metabolism Journal

Abstract

BACKGROUND: The detection of glutamic acid decarboxylase 65 (GAD65) autoantibodies is essential for the prediction and diagnosis of latent autoimmune diabetes in adults (LADA). The aim of the current study was to compare a newly developed electrochemiluminescence (ECL)-GAD65 antibody assay with the established radiobinding assay, and to explore whether the new assay could be used to define LADA more precisely. METHODS: Serum samples were harvested from 141 patients with LADA, 95 with type 1 diabetes mellitus, and 99 with type 2 diabetes mellitus, and tested for GAD65 autoantibodies using both the radiobinding assay and ECL assay. A glutamic acid decarboxylase antibodies (GADA) competition assay was also performed to assess antibody affinity. Furthermore, the clinical features of these patients were compared. RESULTS: <0.05), and were more likely to have other diabetes-associated autoantibodies. The β-cell function of ECL-GAD65 antibody-positive patients was similar to that of type 1 diabetes mellitus patients, whereas ECL-GAD65 antibody-negative patients were more similar to type 2 diabetes mellitus patients. CONCLUSION: Patients with ECL-GAD65 antibody-negative share a similar phenotype with type 2 diabetes mellitus patients, whereas patients with ECL-GAD65 antibody-positive resemble those with type 1 diabetes mellitus. Thus, the detection of GADA using ECL may help to identify the subtype of LADA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4093/dmj.2019.0007

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhu, Y., Qian, L., Liu, Q., Zou, J., Zhou, Y., Yang, T., Huang, G., Zhou, Z., & Liu, Y.
Affiliations
  • Nanjing Medical University (CN)
  • Department of Endocrinology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
  • Jiangsu Province Hospital (CN)
  • Central South University (CN)
Corresponding author
Liu, Yu
Venue
Diabetes & Metabolism Journal
Published
2020
Volume
44
Issue
2
Pages
260
ISSN
  • 2233-6079 (ISSN-L)
  • 2233-6087
OpenAlex
W2984743897
Cited by
26
References
21
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 3
FWCI
1.81
Type
journal article
Language
en
Open access
Locations
  • Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Key Research and Development Program of China (2016YFC1305000, 2016YFC1305005)
  • Nanjing Science and Technology Committee (201605084)
  • National Natural Science Foundation of China (81770778, 81570704)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
latent autoimmune diabetes in adults, GAD65 antibodies, glutamic acid decarboxylase, electrochemiluminescence assay, radiobinding assay, type 1 diabetes, type 2 diabetes, beta-cell function, diabetes autoantibodies, antibody affinity
MeSH terms
Latent Autoimmune Diabetes in Adults, Adolescent, Adult, Autoantibodies, C-Peptide, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glutamate Decarboxylase, Humans, Islets of Langerhans, Male, Middle Aged, Phenotype, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review